Hyundai Boston Dynamics ownership is now complete. A Q3 filing shows all options were exercised, so Hyundai Motor Group affiliates and Chairman Chung hold 100 percent of the robotics company, as Korean outlets report. The move follows SoftBank’s decision to exercise its put option, which Hyundai addressed in a July statement.

Why the deal matters
Hyundai says full ownership strengthens its long-term robotics strategy. It is building what it calls an end-to-end AI robotics value chain. That chain combines Boston Dynamics’ AI expertise with the group’s manufacturing and mobility strengths. In addition, owning the whole company removes a major uncertainty about who controls the technology.
Atlas heads to the factory floor
Hyundai plans to deploy the Atlas humanoid at its Georgia Metaplant starting in 2028, first for parts sequencing. It expects Atlas to move into component assembly by 2030, subject to validation and business needs. Reports also mention capacity for up to 30,000 Atlas units per year. However, those plans still depend on the robot passing real-world tests.
Recent demos and what comes next
Recent Atlas demonstrations included delivering the ceremonial match ball at a FIFA World Cup 2026 game. Another showed the robot lifting and moving a 23-kilogram refrigerator. Meanwhile, an IPO is reported for 2027, though Hyundai has not confirmed the timing.
For the wider industry, this is a clear signal. Carmakers are betting that humanoid robots will become factory workers, not just viral videos. Therefore, expect more automakers to chase similar deals. Keep an eye on the Georgia pilot, since it will show whether the hype can turn into real output.
What does it mean for investors? With a 100 percent stake, Hyundai can plan spending and a listing without negotiating with outside holders. Also, a 2027 IPO, if it happens, would let the market value the company directly. Meanwhile, rivals in humanoid robotics will watch how fast Atlas leaves the lab. Treat the timelines as targets, since Hyundai says its plans remain subject to approvals.
